Početna › Neuroblastom › Tennessee
Kliničke studije za Neuroblastom u državi Tennessee
12 studija za Neuroblastom traži sudionike na lokacijama u državi Tennessee.
Gradovi u državi Tennessee
Službeni tekst studije (engleski)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- East Tennessee Childrens Hospital, Knoxville
- Saint Jude Children's Research Hospital, Memphis
- The Children's Hospital at TriStar Centennial, Nashville
- i još 1
U tijeku regrutacijaFaza 3
Do 30 godina · Oba spola · Ažurirano 2. lis 2026. · NCT06172296Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- Monroe Carrell Jr. Children's Hospital at Vanderbilt, Nashville
U tijeku regrutacijaFaza 1/2
Do 26 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06465199Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Monroe Carrell Jr. Children's Hospital at Vanderbilt, Nashville
U tijeku regrutacijaFaza 1/2
Do 30 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06541262Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
- Monroe Carrell Jr. Children's Hospital at Vanderbilt, Nashville
U tijeku regrutacijaFaza 2
Od 1 do 21 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06540963Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- East Tennessee Childrens Hospital, Knoxville
- Saint Jude Children's Research Hospital, Memphis
- The Children's Hospital at TriStar Centennial, Nashville
- i još 1
U tijeku regrutacijaFaza 3
365 Days – 30 Years · Oba spola · Ažurirano 25. kol 2026. · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Saint Jude Children's Research Hospital, Memphis
U tijeku regrutacijaFaza 1/2
12 Months – 30 Years · Oba spola · Ažurirano 25. kol 2026. · NCT04851119NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
- St. Jude Children's Research Hospital, Memphis
U tijeku regrutacijaFaza 2
Od 1 do 31 godina · Oba spola · Ažurirano 20. srp 2026. · NCT06450041Familial Investigations of Childhood Cancer Predisposition
- St. Jude Children's Research Hospital, Memphis
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 17. lip 2026. · NCT03050268B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
- St. Jude Children's Research Hospital, Memphis
U tijeku regrutacijaFaza 1
Do 21 godina · Oba spola · Ažurirano 19. svi 2026. · NCT04897321Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- St. Jude Children's Research Hospital, Memphis
U tijeku regrutacijaFaza 1/2
12 Months – 30 Years · Oba spola · Ažurirano 19. svi 2026. · NCT04901702Neuroblastoma Biology Study
- St. Jude Children's Research Hospital, Memphis
U tijeku regrutacijaOpažajna studija
31 Days – 99 Years · Oba spola · Ažurirano 23. ožu 2026. · NCT01587300Molecular Analysis Of Solid Tumors
- St. Jude Children's Research Hospital, Memphis
U tijeku regrutacijaOpažajna studija
Do 25 godina · Oba spola · Ažurirano 12. stu 2025. · NCT01050296Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.